Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
European Journal of Clinical Pharmacology|January 1, 1986
Atrial natriuretic peptides: reproducibility of renal effects and response of liver blood flowJ Biollaz, B Waeber, J Nussberger, et al.British Journal of Clinical Pharmacology|April 1, 1987
The pharmacokinetics of enalapril in hospitalized patients with congestive heart failureK Dickstein, A E Till, T Aarsland, et al.British Journal of Clinical Pharmacology|May 1, 1985
Effective dose range of enalapril in mild to moderate essential hypertensionR Bergstrand, H Herlitz, S Johansson, et al.British Journal of Clinical Pharmacology|June 1, 1983
The effect of enalapril on serum prolactinW R McNabb, B A Brooks, F Noormohamed, et al.Biopharmaceutics & Drug Disposition|July 1, 1984
Pharmacokinetics of repeated single oral doses of enalapril maleate (MK-421) in normal volunteersA E Till, H J Gomez, M Hichens, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1984
Metabolism of methyldopa in man after oral administration of the pivaloyloxyethyl esterS Vickers, C A Duncan, H G Ramjit, et al.British Journal of Clinical Pharmacology|September 1, 1982
Enalapril maleate and a lysine analogue (MK-521): disposition in manE H Ulm, M Hichens, H J Gomez, et al.Journal of Cardiovascular Pharmacology|January 1, 1986
Dose-dependent effect of atrial natriuretic peptide on blood pressure, heart rate, and skin blood flow of normal volunteersJ P Bussien, J Biollaz, B Waeber, et al.British Journal of Clinical Pharmacology|September 1, 1982
Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin systemJ Biollaz, J L Schelling, B Jacot Des Combes, et al.Clinical Pharmacology and Therapeutics|May 1, 1981
Three new long-acting converting-enzyme inhibitors: relationship between plasma converting-enzyme activity and response to angiotensin IJ Biollaz, M Burnier, G A Turini, et al.Pageof 4